| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.38B | 99.98B | 96.99B | 93.36B | 88.42B | 91.03B |
| Gross Profit | 20.50B | 19.11B | 18.19B | 16.30B | 15.31B | 15.55B |
| EBITDA | 7.84B | 8.38B | 7.43B | 6.92B | 6.81B | 6.71B |
| Net Income | 3.76B | 3.31B | 1.50B | 1.25B | 684.00M | 825.00M |
Balance Sheet | ||||||
| Total Assets | 126.09B | 128.89B | 134.60B | 123.47B | 129.12B | 129.08B |
| Cash, Cash Equivalents and Short-Term Investments | 10.24B | 12.25B | 11.01B | 10.56B | 8.95B | 12.81B |
| Total Debt | 11.40B | 13.02B | 15.51B | 13.00B | 28.28B | 28.37B |
| Total Liabilities | 60.81B | 65.97B | 71.47B | 65.75B | 67.84B | 66.13B |
| Stockholders Equity | 65.25B | 62.89B | 63.08B | 57.69B | 61.16B | 62.82B |
Cash Flow | ||||||
| Free Cash Flow | 2.94B | 2.63B | -254.00M | 16.36B | -2.47B | -2.74B |
| Operating Cash Flow | 7.13B | 6.74B | 3.11B | 23.41B | 5.42B | 5.64B |
| Investing Cash Flow | -519.00M | -902.00M | -2.91B | -4.42B | -6.63B | -7.40B |
| Financing Cash Flow | -7.92B | -4.64B | 266.00M | -17.36B | -2.62B | 1.53B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥1.37T | 11.76 | 7.04% | 1.47% | 3.37% | -31.10% | |
74 Outperform | ¥1.24T | 11.67 | 6.28% | 1.07% | 3.01% | 6.48% | |
71 Outperform | ¥115.05B | 21.77 | 19.59% | 0.16% | 18.08% | 136.77% | |
68 Neutral | ¥41.37B | 7.42 | ― | 3.71% | -0.04% | 93.95% | |
66 Neutral | ¥9.66B | 2.00 | ― | 2.83% | 2.55% | 44.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥5.47B | -22.35 | ― | 2.72% | -1.30% | ― |